Mark A. Velleca's Net Worth
$9.1 Million
Who is Mark A. Velleca?
Mark A. Velleca has an estimated net worth of $9.1 Million. This is based on reported shares across multiple companies, which include G1 Therapeutics, Inc., and Black Diamond Therapeutics, Inc..
SEC CIK
Mark A. Velleca's CIK is 0001706847
Past Insider Trading and Trends
2021 was Mark A. Velleca's most active year for acquiring shares with 22 total transactions. Mark A. Velleca's most active month to acquire stocks was the month of December. 2021 was Mark A. Velleca's most active year for disposing of shares, totalling 42 transactions. Mark A. Velleca's most active month to dispose stocks was the month of January. 2021 saw Mark A. Velleca paying a total of $298,828.80 for 275,040 shares, this is the most they've acquired in one year. In 2022 Mark A. Velleca cashed out on 245,000 shares for a total of $1,456,437.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
G1 Therapeutics, Inc. (GTHX) Snapshot price: $7.12
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$1.20 | -$96,818.34 | 116K |
Aug 8
| |||
Form 4
|
—
|
0
|
$6.05 | -$169,639.50 | 116K |
Scheduled
|
Oct 18
| ||
Form 4
|
—
|
0
|
$6.95 | -$262,244.00 | 116K |
Scheduled
|
Sep 20
| ||
Form 4
|
—
|
0
|
$6.52 | -$979,704.00 | 116K |
Scheduled
|
Aug 16
| ||
Form 4
| +14.85% | 15K |
$0.39 | $5,850.00 | 116K |
Feb 7
| |||
Form 4
| +65.57% | 40K |
$0.39 | $15,600.00 | 101K |
Nov 9
| |||
Form 4
|
—
|
0
|
$9.70 | -$558,558.00 | 61K |
Scheduled
|
Jul 13 - Jul 15
| ||
Form 4
|
—
|
0
|
$11.18 | -$647,321.00 | 61K |
Scheduled
|
Jun 15 - Jun 17
| ||
Form 4
| +48.78% | 20K |
$0.39 | $7,800.00 | 61K |
May 25
| |||
Form 4
|
—
|
0
|
$10.15 | -$585,401.00 | 41K |
Scheduled
|
May 11 - May 13
| ||
Form 4
|
—
|
0
|
$12.43 | -$722,068.00 | 41K |
Scheduled
|
Apr 13 - Apr 15
| ||
Form 4
|
—
|
0
|
$16.77 | -$809,769.34 | 41K |
Scheduled
|
Feb 16 - Feb 18
| ||
Form 4
| +10.81% | 4K |
$12.17 | -$517,128.00 | 41K |
Scheduled
|
Jan 19 - Jan 21
| ||
Form 4
|
—
|
0
|
$11.63 | -$474,386.00 | 37K |
Scheduled
|
Dec 15 - Dec 17
| ||
Form 4
| +8.82% | 3K |
$0.39 | $1,170.00 | 37K |
Mar 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 4
| +21.43% | 6K |
$0.39 | $2,340.00 | 34K |
Jan 23
| |||
Form 4
| +47.37% | 9K |
$0.39 | $3,510.00 | 28K |
Jan 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
$21.78 | -$180,610.75 | 19K |
Scheduled
|
Nov 15
| ||
Form 4
| +111.11% | 10K |
$21.52 | -$185,145.34 | 19K |
Scheduled
|
Oct 11 - Oct 15
| ||
Form 4
|
—
|
0
|
$35.02 | -$312,949.06 | 9K |
Scheduled
|
Sep 17
| ||
Form 4
|
—
|
0
|
$29.80 | -$260,778.01 | 9K |
Scheduled
|
Aug 15
| ||
Form 4
| -10.00% | -1.00K |
$22.89 | -$191,713.12 | 9K |
Scheduled
|
Jun 22 - Jul 16
| ||
Form 4
|
∞
| 10K |
$0.39 | $3,900.00 | 10K |
May 31
| |||
Form 4
|
—
|
0
|
$25.00 | -$319,164.11 |
0
|
Scheduled
|
May 15
| ||
Form 4
|
—
|
0
|
$19.86 | -$242,071.40 |
0
|
Scheduled
|
Apr 16
| ||
Form 4
|
—
|
0
|
$20.96 | -$258,566.25 |
0
|
Scheduled
|
Mar 15
| ||
Form 4
|
—
|
0
|
$11.86 | -$122,115.00 |
0
|
Scheduled
|
Feb 15
| ||
Form 4
|
—
|
0
|
$13.35 | -$144,495.00 |
0
|
Scheduled
|
Jan 16
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
$11.87 | -$122,205.75 |
0
|
Scheduled
|
Dec 18
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Black Diamond Therapeutics, Inc. (BDTX) Snapshot price: $5.4
PRESIDENT & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
| +12.61% | 5.21K |
$3.60 | $18,748.80 | 46.52K |
Sep 15 - Sep 17
| |||
Form 4
| +27.57% | 8.93K |
$2.10 | $18,750.90 | 41.31K |
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
| +53.07% | 11.23K |
$1.67 | $18,750.76 | 32.38K |
Mar 16
| |||
Form 4
| +66.16% | 8.42K |
$1.50 | $12,636.00 | 21.16K |
Dec 16
| |||
Form 4
| +50.88% | 4.29K |
$2.62 | $11,250.28 | 12.73K |
Sep 16
| |||
Form 4
| +191.30% | 5.54K |
$2.03 | $11,250.26 | 8.44K |
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
∞
| 2.9K |
$3.02 | $8,748.94 | 2.9K |
Mar 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||